Beckman Laser Institute, Unversity of California Irvine
Irvine, California, 92612, United States
NCT Number: NCT00540566
This study is to compare the ability of optical biopsy. Research can use light enters the skin, collected, analyzed by the computer, and a picture created for the pathologist to conventional histologic examination compare with the pathologist looking at the piece of tissue through a microscope makes the diagnosis.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Irvine, California, 92612, United States
The Optical measurements provide quantitative optical property values that reflect changes in tissue perfusion, oxygen consumption, and cell/matrix development. Each measurement requires less than 5 minutes to execute. The measurements will be taken before and after skin treatment.This non-invasive, non-contact technique has great potential as a means to diagnose different skin problems without the need to obtain a piece of tissue from the skin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Optical Biopsy imaging
Time frame: 12 weeks
University of California, Irvine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04229277
Basal Cell Carcinoma, Carcinoma
Copenhagen, Denmark
View Trial DetailsNCT03545334
Adenocarcinoma, Carcinoma
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT01017185
Breast Diseases, Breast Neoplasms
The Bronx, New York, United States
View Trial DetailsNCT00324272
Carcinoma, Carcinoma, Squamous Cell
View Trial Details